| Date Filed | Type | Description |
| 10/06/2023 |
4
| Rashid Kashif (General Counsel) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 1,879 shares
@ $18.07, valued at
$34k
|
|
| 10/03/2023 |
4
| Kosaraju Sridhar (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 819 shares
@ $0 |
|
| 10/03/2023 |
4
| WEATHERMAN ELIZABETH H (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 1,030 shares
@ $0 |
|
| 10/03/2023 |
4
| Fischer Frank M (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 871 shares
@ $0 |
|
| 10/03/2023 |
4
| DEMANE MICHAEL F (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 1,365 shares
@ $0 |
|
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2023 |
4
| DEMANE MICHAEL F (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 1,032 shares
@ $0 |
|
| 07/05/2023 |
4
| Kosaraju Sridhar (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 619 shares
@ $0 |
|
| 07/05/2023 |
4
| WEATHERMAN ELIZABETH H (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 779 shares
@ $0 |
|
| 07/05/2023 |
4
| Fischer Frank M (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 658 shares
@ $0 |
|
| 06/09/2023 |
4
| McCormick Shawn (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Bought 7,500 shares
@ $22.8844, valued at
$171.6k
|
|
| 06/09/2023 |
4
| DEMANE MICHAEL F (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Gifted 80,000 shares
@ $0 |
|
| 06/06/2023 |
4
| Rashid Kashif (General Counsel) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 450 shares
@ $28.27, valued at
$12.7k
|
|
| 06/06/2023 |
4
| GROSSMAN D KEITH (Executive Chairman) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 2,193 shares
@ $28.27, valued at
$62k
|
|
| 05/31/2023 |
4
| MacLeod Roderick H. (CFO) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 800 shares
@ $26.45, valued at
$21.2k
|
|
| 05/31/2023 |
4
| Rashid Kashif (General Counsel) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 800 shares
@ $26.45, valued at
$21.2k
|
|
| 05/31/2023 |
4
| Pellegrini Niamh Louise (Chief Commercial Officer) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 1,143 shares
@ $26.45, valued at
$30.2k
|
|
| 05/30/2023 |
4
| DEMANE MICHAEL F (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 6,754 shares
@ $0 |
|
| 05/30/2023 |
4
| SIEGEL SUSAN E (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 6,754 shares
@ $0 |
|
| 05/30/2023 |
4
| WEATHERMAN ELIZABETH H (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 6,754 shares
@ $0 |
|
| 05/30/2023 |
4
| OBOYLE KEVIN C (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 6,754 shares
@ $0 |
|
| 05/30/2023 |
4
| Fischer Frank M (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 6,754 shares
@ $0 |
|
| 05/30/2023 |
4
| Kosaraju Sridhar (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 6,754 shares
@ $0 |
|
| 05/30/2023 |
4
| McCormick Shawn (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 6,754 shares
@ $0 |
|
| 05/30/2023 |
4
| Prange Karen (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 6,754 shares
@ $0 |
|
| 04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2023 |
4
| GROSSMAN D KEITH (Chairman, President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 4,263 shares
@ $35.66, valued at
$152k
|
|
| 04/04/2023 |
4
| WEATHERMAN ELIZABETH H (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 548 shares
@ $0 |
|
| 04/04/2023 |
4
| Fischer Frank M (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 463 shares
@ $0 |
|
| 04/04/2023 |
4
| DEMANE MICHAEL F (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 726 shares
@ $0 |
|
| 04/04/2023 |
4
| Kosaraju Sridhar (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 435 shares
@ $0 |
|
| 03/14/2023 |
4
| GROSSMAN D KEITH (Chairman, President & CEO) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 2,757 shares
@ $30.19, valued at
$83.2k
|
|
|